Q1 2026 Financial Highlights
- Revenues of
$14.3 million , up 23% as compared to$11.7 million in Q1 2025. - Gross profit of
$5.1 million , up 11% as compared to$4.6 million in Q1 2025. - Adjusted EBITDA* was
$0.4 million , compared to$0.08 million in Q1 2025. - Net loss was
$0.4 million (or$0.00 per basic and diluted share), improved from a net loss of$1.2 million (or$0.01 per basic and diluted share) in Q1 2025. - Cash and cash equivalents as of
March 31, 2026 was$15.8 million , as compared to$14.9 million atDecember 31, 2025 . - No long-term debt; the remaining long-term obligations were paid off during the quarter.
* Q1 2026 Adjusted EBITDA excludes certain non-cash expenses, including stock-based compensation of
Q1 2026 Operational Highlights
- Total backlog reached a record
$273.3 million as ofMarch 31, 2026 , up from$265 million atDecember 31, 2025 . - Qualified pipeline totaled
$938 million as ofMarch 31, 2026 , up from$817 million atDecember 31, 2025 , reflecting a substantial increase in identified opportunities.
Discussing the go-forward strategy,
About
Forward-Looking Statements:
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 2lE of the Securities Exchange Act of 1934, as amended. These forward-looking statements represent the Company's expectations or beliefs concerning future events and can generally be identified by the use of statements that include words such as "estimate," "project," "believe," "anticipate," "shooting to," "intend," "in a position," "looking to," "pursue," "positioned," "will," "likely," "would," or similar words or phrases. Forward-looking statements include, but are not limited to, statements regarding the Company's expectations for revenue growth, new customer opportunities, improvements to cost structure, and profitability. These forward-looking statements are subject to risks, uncertainties, and other factors, many of which are outside of the Company's control, that could cause actual results to differ (sometimes materially) from the results expressed or implied in the forward-looking statements, including, among others: the Company's ability to continue to grow and execute on its total backlog and qualified pipeline and compete against new and existing competitors; its ability to effectively integrate and grow its acquired companies; its ability to identify additional acquisition targets and close additional acquisitions; and the Company's ability to maintain the listing of its common stock on the
Contacts:
Investor Relations:
The Equity Group
(212) 836-9611
lcati@theequitygroup.com
(212) 836-9633
vferraro@theequitygroup.com
| Consolidated Balance Sheets | |||||||
| (Unaudited) | |||||||
2026 | 2025 | ||||||
| (unaudited) | |||||||
| Assets | |||||||
| Current Assets: | |||||||
| Cash | $ | 15,772,974 | $ | 14,884,778 | |||
| Accounts receivable, net | 7,714,969 | 8,180,180 | |||||
| Contract asset | 541,441 | 568,705 | |||||
| Due from buyer | 57,049 | 58,207 | |||||
| Prepaid income taxes | 146,245 | 153,153 | |||||
| Prepaid expenses and other current assets | 764,894 | 800,671 | |||||
| Total current assets | 24,997,572 | 24,645,694 | |||||
| Fixed assets, net | 220,419 | 231,136 | |||||
| Non-Current Assets: | |||||||
| Due from buyer, net of current portion | 44,371 | 77,259 | |||||
| Right of use asset - operating lease | 718,137 | 800,069 | |||||
| Investment in joint ventures/captive insurance entity | 100,250 | 100,250 | |||||
| Intangible assets, net | 5,067,056 | 5,371,602 | |||||
| 10,676,834 | 10,676,834 | ||||||
| Total non-current assets | 16,827,067 | 17,257,150 | |||||
| Total Assets | $ | 41,824,639 | $ | 41,902,844 | |||
| Liabilities and Stockholders' Equity | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued expenses | $ | 1,981,584 | $ | 1,904,962 | |||
| Accrued payroll and payroll related expenses | 2,952,153 | 2,761,998 | |||||
| Current portion of lease liability – operating leases | 251,073 | 270,868 | |||||
| Derivative liability | 10,000 | 262,000 | |||||
| Notes payable, related party | — | 400,000 | |||||
| Total current liabilities | 5,194,810 | 5,599,828 | |||||
| Non-Current Liabilities | |||||||
| Lease liability – operating leases, net of current portion | 487,188 | 550,219 | |||||
| Total non-current liabilities | 487,188 | 550,219 | |||||
| Total Liabilities | $ | 5,681,998 | $ | 6,150,047 | |||
| Stockholders' Equity | |||||||
| Preferred stock, 50,000,000 shares authorized | |||||||
| Series A Preferred stock, par value | 588 | 588 | |||||
| Series C Preferred stock, par value | 57 | 57 | |||||
| Common stock, par value, | 9,461 | 9,461 | |||||
| Additional paid in capital | 93,098,846 | 92,330,909 | |||||
| Accumulated deficit | (56,966,311 | ) | (56,588,218 | ) | |||
| Total stockholders' equity | 36,142,641 | 35,752,797 | |||||
| Total Liabilities and Stockholders' Equity | $ | 41,824,639 | $ | 41,902,844 | |||
| Consolidated Statements of Operations | |||||||
| (Unaudited) | |||||||
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| Revenues | $ | 14,291,961 | $ | 11,664,365 | |||
| Cost of Revenues | 9,229,741 | 7,109,749 | |||||
| Gross Profit | 5,062,220 | 4,554,616 | |||||
| Operating Expenses | |||||||
| Indirect costs | 2,461,140 | 2,385,544 | |||||
| Overhead | 644,356 | 512,924 | |||||
| General and administrative | 2,654,722 | 3,142,155 | |||||
| Total operating expenses | 5,760,218 | 6,040,623 | |||||
| Loss From Operations Before Other Income | (697,998 | ) | (1,486,007 | ) | |||
| Other Income (Expense) | |||||||
| Gain from change in fair value of derivative liability | 252,000 | 501,000 | |||||
| Interest income (expense), net | 101,400 | (110,764 | ) | ||||
| Total other income | 353,400 | 390,236 | |||||
| Loss Before Income Taxes and Preferred Stock Dividends | (344,598 | ) | (1,095,771 | ) | |||
| Income tax benefit (expense) | (6,676 | ) | (74,276 | ) | |||
| Net Loss | (351,274 | ) | (1,170,047 | ) | |||
| Less: preferred stock dividends | 26,819 | 26,984 | |||||
| Net Loss To Common Shareholders | $ | (378,093 | ) | $ | (1,197,031 | ) | |
| Net Loss Per Share - Basic And Diluted | $ | 0.00 | $ | (0.01 | ) | ||
| Weighted Average Shares Outstanding - Basic And Diluted | 94,612,750 | 80,953,373 | |||||
Non-GAAP Financial Measures and Key Performance Metrics
This press release contains Non-GAAP Adjusted EBITDA, which is a Non-GAAP financial measure that is used by management to measure the Company's operating performance. A reconciliation of this measure to the most directly comparable GAAP financial measure is contained herein. To the extent required, statements disclosing this measure's definition, utility, and purpose are also set forth herein.
Definition:
Adjusted EBITDA is a Non-GAAP measure, calculated as the Company’s earnings before (not including expenses related to) interest, taxes, depreciation, and amortization, also adjusted for other non-cash items such as stock-based compensation, and other non-recurring cash items, such as expenses for a one-time policy change.
Utility and Purpose:
The Company discloses Non-GAAP Adjusted EBITDA because this Non-GAAP measure is used by management to evaluate our business, measure its operating performance, and make strategic decisions. We believe Non-GAAP Adjusted EBITDA is useful for investors and others in understanding and evaluating our operating results in the same manner as its management. However, Non-GAAP Adjusted EBITDA is not a financial measure calculated in accordance with GAAP and should not be considered as a substitute for GAAP operating loss or any other operating performance measure calculated in accordance with GAAP. Using this Non-GAAP measure to analyze our business would have material limitations because the calculations are based on the subjective determination of management regarding the nature and classification of events and circumstances that investors may find significant. In addition, although other companies in our industry may report a measure titled Non-GAAP Adjusted EBITDA, this measure may be calculated differently from how we calculate this Non-GAAP financial measure, which reduces its overall usefulness as a comparative measure. Because of these inherent limitations, you should consider Non-GAAP Adjusted EBITDA alongside other financial performance measures, including net loss and our other financial results presented in accordance with GAAP.
| Reconciliation of Unaudited Non-GAAP Adjusted EBITDA to Operating Income/ (Loss) | |||||||
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| Revenues | $ | 14,291,961 | $ | 11,664,365 | |||
| Gross profit | 5,062,221 | 4,554,616 | |||||
| Loss from operations before other income (expense) | (697,998 | ) | (1,482,366 | ) | |||
| Add Back: | |||||||
| Depreciation and amortization | 324,991 | 378,187 | |||||
| Adjust for non-cash and one-time charges | |||||||
| Stock based compensation | 767,937 | 1,179,209 | |||||
| Non-recurring charges | - | - | |||||
| Total non-cash charges | 767,937 | 1,179,209 | |||||
| Non-GAAP Adjusted EBITDA | $ | 394,930 | $ | 75,030 | |||
Source: